UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000014285
Receipt number R000016637
Scientific Title Examination of odor perception and emotion changes in patients undergoing chemotherapy
Date of disclosure of the study information 2014/06/18
Last modified on 2016/05/05 17:26:25

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Examination of odor perception and emotion changes in patients undergoing chemotherapy

Acronym

Examination of odor perception and emotion changes in patients undergoing chemotherapy

Scientific Title

Examination of odor perception and emotion changes in patients undergoing chemotherapy

Scientific Title:Acronym

Examination of odor perception and emotion changes in patients undergoing chemotherapy

Region

Japan


Condition

Condition

digestive cancer

Classification by specialty

Gastrointestinal surgery

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

We try to estimate the odor perception changes of the patients with the anticancer drug administration. At the same time, We try to grasp the emotion changes in patients for smells of Odor Stick Identification Test for Japanese(OSIT-J).

Basic objectives2

Pharmacodynamics

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2

Pragmatic

Developmental phase



Assessment

Primary outcomes

Odor Stick Identification Test for Japanese(OSIT-J)

The intervention times of the examination of odor perception are at the three times that are ago, during, after the anticancer drug administration in one anticancer drug treatment course.

Key secondary outcomes

1.Visual Analogue Scale(VAS) estimating emotion affected by odor perception
2. physiological indicators
temperature, percutaneous oxygen saturation of the arterial blood, a pulse rate, blood pressure
3. Biochemical examination of blood
Alb, Hgb, Hct, RBC, WBC, Lympho, Plt, MCV, Cr, BUN, FBS, AST, ALT, Na
4. The questionnaire writing by oneself about the smell

The intervention times are at the three times that are ago, during, after the anticancer drug administration in one anticancer drug treatment course.
However,we do not perform the biochemical examination of blood during treatment with anticancer drug.


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Historical

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Other

Interventions/Control_1

The subjects perform in the same patient, the intervention times of the examination of odor perception and emotion are at the three times that are ago, during, after the anticancer drug administration in one anticancer drug treatment course.
The investigation contents are odor Stick Identification Test for Japanese (OSIT-J), Visual Analogue Scale(VAS) estimating emotion affected by odor perception, physiological indicators, biochemical examination of blood, and the questionnaire writing by oneself about the smell.However,we do not perform the biochemical examination of blood during treatment with anticancer drug.
Identification Test for Japanese (OSIT-J) uses 12 kinds of odorant (China ink, wood, perfume, menthol, orange, curry, home gas, rose, hinoki, steamed socks, condensed milk, the fried garlic).

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

The inpatients, communication does not have a hindrance, are adults who
are treated with the digestive cancer chemotherapy, and are available for oral intake , and 20 years-old or older.

Key exclusion criteria

The persons except the key inclusion criteria

Target sample size

10


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Hitoshi Okamura

Organization

Institute of Biomedical and Health Sciences, Hiroshima University

Division name

Psychosocial Rehabilitation Laboratory

Zip code


Address

2-3,Kasumi 1-chome, Minami-ku, Hiroshima, Japan

TEL

082-257-5450

Email

hokamura@hiroshima-u.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Kojiro Ishinaga

Organization

Graduate School of Biomedical and Health Sciences, Hiroshima University

Division name

Psychosocial Rehabilitation Laboratory

Zip code


Address

2-3,Kasumi 1-chome, Minami-ku, Hiroshima, Japan

TEL

082-555-8265

Homepage URL


Email

koujirou@gaines.hju.ac.jp


Sponsor or person

Institute

National Hospital Higashi Hiroshima Medical Center

Institute

Department

Personal name



Funding Source

Organization

Hiroshima Jogakuin University

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor

National Hospital Higashi Hiroshima Medical Center

Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

国立病院機構東広島医療センター(広島県)


Other administrative information

Date of disclosure of the study information

2014 Year 06 Month 18 Day


Related information

URL releasing protocol


Publication of results

Published


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results

We investigated a change of odor identification ability using Odor Stick Identification Test for Japanese in ten patients who have received the sequential chemotherapy of FOLFIRI or modified FOLFOX6 therapy.
As a result, we was speculated that the odor identification ability did not decrease, because the significant difference was not found at three times of the examination of odor perception that are ago, during, after the anticancer drug administration in one anticancer drug treatment course.
But, patients felt heightened sensitivity to odors, we was thought to have possibilities to appear that heightened sensitivity to odors were stress reaction related to protect oneself as evidenced by pulses increased after anticancer drug administration, when patients felt emotional psychologic stresses by anticancer drug administration.

Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2014 Year 05 Month 30 Day

Date of IRB


Anticipated trial start date

2014 Year 06 Month 18 Day

Last follow-up date

2015 Year 03 Month 31 Day

Date of closure to data entry

2015 Year 07 Month 31 Day

Date trial data considered complete

2015 Year 09 Month 30 Day

Date analysis concluded

2016 Year 03 Month 31 Day


Other

Other related information



Management information

Registered date

2014 Year 06 Month 17 Day

Last modified on

2016 Year 05 Month 05 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000016637


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name